REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

St. Vincent's Hosptial Sydney, Darlinghurst

Icon Cancer Care South Brisbane, South Brisbane

Linear Clinical Research Ltd, Nedlands

Memorial Sloan Kettering Cancer Center, New York

Karolinska University Hospital, Stockholm

Fox Chase Cancer Center, Philadelphia

Istituto Europeo di Oncologia, Milan

Centre Georges François Leclerc, Dijon

Hospital Universitario Fundación Jiménez Díaz- START MADRID, Madrid

Hospital Universitario HM Sanchinarro-START MADRID-CIOCC, Madrid

Winship Cancer Institute, Emory University, Atlanta

Medizinische Hochschule Hannover, Hanover

Clinica de Universidad de Navarra, Pamplona

Mayo Clinic, Jacksonville

Institut Bergonie, Bordeaux

Moffitt Cancer Center, Tampa

The University of Alabama at Birmingham, Birmingham

China Medical University Hospital, Taichung

Taussig Cancer Institute Cleveland Clinic, Cleveland

Hospital Clínico Universitario de Valencia, Valencia

University of Michigan, Ann Arbor

Mayo Clinic, Rochester

University of Chicago Medical Center, Chicago

Universitätsklinikum Heidelberg, Heidelberg

Centre Leon Berard, Lyon

Texas Oncology, Dallas

The University of Texas M.D. Anderson Cancer Center, Houston

LMU Klinikum, Campus Grosshadern, Munich

Huntsman Cancer Institute, University of Utah, Salt Lake City

Mayo Clinic, Phoenix

USC Norris Comprehensive Cancer Center, Los Angeles

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Gustave Roussy Cancer Campus, Paris

Virginia Mason Medical Center, Seattle

National Cancer Center Singapore, Singapore

Queen Mary Hospital, Hong Kong

Massachusetts General Hospital, Boston

Netherlands Cancer institute, Amsterdam

Erasmus MC, Rotterdam

Seoul National University Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

START Barcelona-Hospital HM Nou Delfos, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

Guy's Hospital, London

Sarah Cannon Research Institute UK, London

University College London Hospitals NHS Foundation Trust, London

The Christie NHS Foundation Trust, Manchester